ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results
- Friday, November 6, 2020, 7:11
- Environment
- Add a comment
Third quarter 2020 revenue of $129 million Third quarter 2020 net loss of $42 million Third quarter 2020 Adjusted EBITDA1 of $53 million Generated cash flow from operations of $113 million in the first nine months of 2020 Concluded the quarter with a cash and cash equivalents balance of…
About the Author
adminasapcorp has written 39429 stories on this site.